Literature DB >> 23819753

Predicting chronic obstructive pulmonary disease hospitalizations based on concurrent influenza activity.

Alicia K Gerke1, Fan Tang, Ming Yang, Eric D Foster, Joseph E Cavanaugh, Philip M Polgreen.   

Abstract

Although influenza has been associated with chronic obstructive pulmonary disease (COPD) exacerbations, it is not clear the extent to which this association affects healthcare use in the United States. The first goal of this project was to determine to what extent the incidence of COPD hospitalizations is associated with seasonal influenza. Second, as a natural experiment, we used influenza activity to help predict COPD admissions during the 2009 H1N1 influenza pandemic. To do this, we identified all hospitalizations between 1998 and 2010 in the Nationwide Inpatient Sample from the Healthcare Cost and Utilization Project (HCUP) during which a primary diagnosis of COPD was recorded. Separately, we identified all hospitalizations during which a diagnosis of influenza was recorded. We formulated time series regression models to investigate the association of monthly COPD admissions with influenza incidence. Finally, we applied these models, fit using 1998-2008 data, to forecast monthly COPD admissions during the 2009 pandemic. Based on time series regression models, a strong, significant association exists between concurrent influenza activity and incidence of COPD hospitalizations (p-value < 0.0001). The association is especially strong among older patients requiring mechanical ventilation. Use of influenza data to predict COPD admissions during the 2009 H1N1 pandemic reduced the mean-squared prediction error by 29.9%. We conclude that influenza activity is significantly associated with COPD hospitalizations in the United States and influenza activity can be exploited to more accurately forecast COPD admissions. Our results suggest that improvements in influenza surveillance, prevention, and treatment may decrease hospitalizations of patients diagnosed with COPD.

Entities:  

Mesh:

Year:  2013        PMID: 23819753      PMCID: PMC4041214          DOI: 10.3109/15412555.2013.777400

Source DB:  PubMed          Journal:  COPD        ISSN: 1541-2563            Impact factor:   2.409


  27 in total

1.  The impact of COPD on lung health worldwide: epidemiology and incidence.

Authors:  S Hurd
Journal:  Chest       Date:  2000-02       Impact factor: 9.410

2.  The validity of International Classification of Diseases, Ninth Revision, Clinical Modification diagnosis codes for identifying patients hospitalized for COPD exacerbations.

Authors:  Brian D Stein; Adriana Bautista; Glen T Schumock; Todd A Lee; Jeffery T Charbeneau; Diane S Lauderdale; Edward T Naureckas; David O Meltzer; Jerry A Krishnan
Journal:  Chest       Date:  2011-07-14       Impact factor: 9.410

3.  Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium.

Authors:  W Vincken; J A van Noord; A P M Greefhorst; Th A Bantje; S Kesten; L Korducki; P J G Cornelissen
Journal:  Eur Respir J       Date:  2002-02       Impact factor: 16.671

Review 4.  Seasonal influenza and vaccination coverage.

Authors:  Arnold S Monto
Journal:  Vaccine       Date:  2010-09-07       Impact factor: 3.641

5.  Effect of exacerbations on quality of life in patients with chronic obstructive pulmonary disease: a 2 year follow up study.

Authors:  M Miravitlles; M Ferrer; A Pont; R Zalacain; J L Alvarez-Sala; F Masa; H Verea; C Murio; F Ros; R Vidal
Journal:  Thorax       Date:  2004-05       Impact factor: 9.139

6.  Influenza but not pneumococcal vaccination protects against all-cause mortality in patients with COPD.

Authors:  S Schembri; S Morant; J H Winter; T M MacDonald
Journal:  Thorax       Date:  2009-03-24       Impact factor: 9.139

7.  Detecting influenza epidemics using search engine query data.

Authors:  Jeremy Ginsberg; Matthew H Mohebbi; Rajan S Patel; Lynnette Brammer; Mark S Smolinski; Larry Brilliant
Journal:  Nature       Date:  2009-02-19       Impact factor: 49.962

8.  The use of Twitter to track levels of disease activity and public concern in the U.S. during the influenza A H1N1 pandemic.

Authors:  Alessio Signorini; Alberto Maria Segre; Philip M Polgreen
Journal:  PLoS One       Date:  2011-05-04       Impact factor: 3.240

9.  Oseltamivir treatment of mice before or after mild influenza infection reduced cellular and cytokine inflammation in the lung.

Authors:  Zi Xin Wong; Jessica E Jones; Gary P Anderson; Rosa C Gualano
Journal:  Influenza Other Respir Viruses       Date:  2011-03-31       Impact factor: 4.380

10.  Using Web and social media for influenza surveillance.

Authors:  Courtney D Corley; Diane J Cook; Armin R Mikler; Karan P Singh
Journal:  Adv Exp Med Biol       Date:  2010       Impact factor: 2.622

View more
  5 in total

1.  Electronic cigarette vapor exposure exaggerates the pro-inflammatory response during influenza A viral infection in human distal airway epithelium.

Authors:  Niccolette Schaunaman; Taylor Crue; Diana Cervantes; Kelly Schweitzer; Harrison Robbins; Brian J Day; Mari Numata; Irina Petrache; Hong Wei Chu
Journal:  Arch Toxicol       Date:  2022-06-07       Impact factor: 6.168

Review 2.  The role of viral infections in exacerbations of chronic obstructive pulmonary disease and asthma.

Authors:  Richard Hewitt; Hugo Farne; Andrew Ritchie; Emma Luke; Sebastian L Johnston; Patrick Mallia
Journal:  Ther Adv Respir Dis       Date:  2015-11-26       Impact factor: 4.031

3.  Looking Back on 50 Years of Literature to Understand the Potential Impact of Influenza on Extrapulmonary Medical Outcomes.

Authors:  Joshua Nealon; Nieves Derqui; Caroline de Courville; Tor Biering-Sørensen; Benjamin J Cowling; Harish Nair; Sandra S Chaves
Journal:  Open Forum Infect Dis       Date:  2022-07-21       Impact factor: 4.423

4.  Hypercapnia Suppresses Macrophage Antiviral Activity and Increases Mortality of Influenza A Infection via Akt1.

Authors:  S Marina Casalino-Matsuda; Fei Chen; Francisco J Gonzalez-Gonzalez; Aisha Nair; Sandra Dib; Alex Yemelyanov; Khalilah L Gates; G R Scott Budinger; Greg J Beitel; Peter H S Sporn
Journal:  J Immunol       Date:  2020-06-15       Impact factor: 5.422

5.  Hypercapnia Alters Expression of Immune Response, Nucleosome Assembly and Lipid Metabolism Genes in Differentiated Human Bronchial Epithelial Cells.

Authors:  S Marina Casalino-Matsuda; Naizhen Wang; Peder T Ruhoff; Hiroaki Matsuda; Marie C Nlend; Aisha Nair; Igal Szleifer; Greg J Beitel; Jacob I Sznajder; Peter H S Sporn
Journal:  Sci Rep       Date:  2018-09-10       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.